LEP and metabolic syndrome: Perry and her colleagues propose that anti-dyslipidemia actions of leptin are mediated by the HPA-axis because the infusion of corticosterone reverses leptin-induced improvements on aberrant blood FFAs and ketone bodies as well as hyperglycemia in streptozocin (STZ)-administered diabetic rats (47).